| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
John G. Cox
Also a director
Chief Executive Officer, President and Director
|
63 | Not stated | $2,076,868 | |
|
Erick Lucera
Chief Financial Officer and Treasurer
|
58 |
Since 2025
1 year
|
$2,695,986 | |
|
Johanna Friedl-Naderer
Chief Commercial Officer
|
58 |
Since 2024
2 years
|
$1,086,420 | |
|
Douglas Kerr, M.D., Ph.D
Head of R&D and CMO
Title from the Form 4 dated Oct 20, 2026
|
59 | Not stated | $1,057,598 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 23, 2026 · updated by the 8-K of Jun 22, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Jason Rhodes
Board chair
|
56 |
2017
9 years
|
Not stated |
Nominating and Corporate Governance Committee · Chair
|
None stated | $354,506 | |
|
John G. Cox
CEO
|
63 |
2024
2 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Carlo Incerti
|
67 |
2022
4 years
|
Not stated |
Research and Development Committee
|
None stated | $317,006 | |
|
Catherine Stehman-Breen
|
63 |
2019
7 years
|
Not stated | None stated | Tenaya Therapeutics, Inc. | $327,006 | |
|
Edward Hurwitz
|
62 |
2018
8 years
|
Not stated |
Compensation Committee
|
MacroGenics, Inc. | $317,006 | |
|
Vikram Karnani
|
51 |
2025
1 year
|
Not stated | None stated | Collegium Pharmaceutical, Inc. | $798,986 | |
|
Dirk Kersten
|
51 |
2018
8 years
|
Not stated |
Compensation Committee · Chair
|
None stated | $334,506 | |
|
David Lubner
|
61 |
2020
6 years
|
Not stated |
Audit Committee · Chair
|
Arcellx Inc., Crescent Biopharma, Inc. | $334,506 | |
|
Brian Posner
|
64 |
2025
1 year
|
Not stated | None stated | Arch Capital Group Ltd. | $571,159 | |
|
Barry E. Greene
Joined Jun 22, 2026
|
- | - | Independent | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...